Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

NCT03733210 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck
Carcinoma of the Head and Neck

Interventions

DRUG: Panitumumab-IRDye800
DRUG: 89-Zirconium (Zr-89) Panitumumab
DEVICE: Pinpoint IR IR9000 fluorescence imaging system (FIS)
DEVICE: SPY-PHI IR9000 fluorescence imaging system (FIS)
DEVICE: Explorer Air camera
DEVICE: PDE-NEO II camera
DEVICE: FIS-00 fluorescence imaging system (FIS)
DEVICE: Da Vinci Firefly Imaging System
DEVICE: IGP-ELVIS-v4 Macroscopic Specimen Imager
DEVICE: Vevo 3100 LAZR-X
DEVICE: Pearl Triology Imaging System
DEVICE: Odyssey CLx Imaging System
DEVICE: Leica fluorescence microscope

Sponsor

Andrei Iagaru

Collaborators

[object Object]
[object Object]